Giant Cell Tumor of Tendon Sheath Developed over Chimeric-Free Latissimus Dorsi and Serratus Anterior Muscle Flaps

Abstract

This article describes a rare case of giant cell tumor of the tendon sheath (GCTTS) that was developed over the substance of chimeric-free latissimus dorsi and ­serratus ­anterior muscle flaps performed for lower limb reconstruction. To our knowledge, development of GCTTS over a free flap is first described in the literature. A 71-year-old ­woman was presented with a large protuberant ulcerated tumor mass that was developed over the substance of chimeric free muscle flaps at the foot and ankle. We performed an extensive tumor resection, and the pathology report confirmed the presence of a primary giant cell tumor. The patient was advised to have a below-knee amputation. However, the patient refused the amputation, and 4 months later, she was presented with a metastatic mass proximally at the upper thigh. We believe that the GCTTS was associated with the chronic inflammation of the soft tissue and bones along with the recurrent episodes of infection, mainly due to proteus mirabilis and proteus syndrome (PS). PS may lead to the development of malformations and overgrowth of different tissues in unusual locations. In cases resistant to antibiotics, the radical surgical debridement should be considered as the most effective treatment.

Keywords

giant cell tumor of tendon sheath - proteus syndrome - chimeric-free flap - microsurgery

• References

• 1 Gibbons CL, Khwaja HA, Cole AS, Cooke PH, Athanasou NA. Giant-cell tumour of the tendon sheath in the foot and ankle. J Bone Joint Surg Br 2002; 84 (07) 1000-1003
• 2 Vogrincic GS, O’Connell JX, Gilks CB. Giant cell tumor of tendon sheath is a polyclonal cellular proliferation. Hum Pathol 1997; 28 (07) 815-819
• 3 Hosaka M, Hatori M, Smith R, Kokubun S. Giant cell formation through fusion of cells derived from a human giant cell tumor of tendon sheath. J Orthop Sci 2004; 9 (06) 581-584
• 4 Jaffe HL, Lichtenstein HL, Elsutro CJ. Pigmented ­villonodular synovitis, bursitis, and tenosynovitis. Arch Pathol (Chic) 1941; 31: 731-765
• 5 Goni V, Gopinathan NR, Radotra BD, Viswanathan VK, Logithasan RK, S. B. Giant cell tumour of peroneus brevis tendon sheath—a case report and review of literature. BMJ Case Rep 2012; 2012: bcr0120125703
• 6 Vargaonkar G, Singh V, Arora S. et al. Giant cell tumor of the tendon sheath around the foot and ankle. a report of three cases and a literature review. J Am Podiatr Med Assoc 2015; 105 (03) 249-254
• 7 Monaghan H, Salter DM, Al-Nafussi A. Giant cell tumour of tendon sheath (localised nodular tenosynovitis): clinicopathological features of 71 cases. J Clin Pathol 2001; 54 (05) 404-407
• 8 Vasconez HC, Nisanci M, Lee EY. Giant cell tumour of the flexor tendon sheath of the foot. J Plast Reconstr Aesthet Surg 2008; 61 (07) 815-818
• 9 Kotwal PP, Gupta V, Malhotra R. Giant-cell tumour of the ­tendon sheath. J Bone Joint Surg Br 2000; 82 (04) 571-573
• 10 Reilly KE, Stern PJ, Dale JA. Recurrent giant cell tumors of the tendon sheath. J Hand Surg Am 1999; 24 (06) 1298-1302
• 11 Cohen Jr MM. Proteus syndrome review: molecular, clinical, and pathologic features. Clin Genet 2014; 85 (02) 111-119
• 12 Lougaris V, Salpietro V, Cutrupi M. et al. Proteus syndrome: evaluation of the immunological profile. Orphanet J Rare Dis 2016; 11: 3